American International Group’s Passage Bio PASG Stock Holding History

American International Group’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-921	Closed	-$57K	–	3220
2022 Q1	$57K	Sell	921 -64	-6%	-$5.28K	﹤0.01%	2802
2021 Q4	$125K	Sell	985 -30	-3%	-$4.9K	﹤0.01%	2622
2021 Q3	$202K	Sell	1,015 -24	-2%	-$5.72K	﹤0.01%	2429
2021 Q2	$275	Buy	1,039 +201	+24%	+$62.2K	﹤0.01%	2308
2021 Q1	$293	Buy	838 +115	+16%	+$49.1K	﹤0.01%	2152
2020 Q4	$370	Buy	723 +317	+78%	+$127K	﹤0.01%	1922
2020 Q3	$107K	Sell	406 -9	-2%	-$3.1K	﹤0.01%	2495
2020 Q2	$227K	Buy	+415	New	+$187K	﹤0.01%	2055

Other funds holding PASG

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's PASG Position: Q2 2022 in Review

American International Group sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 921 shares — an estimated $57K sold.

American International Group first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $227K in Q2 2020. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

American International Group reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
American International Group sold 921 Passage Bio shares in Q2 2022, an estimated $57K.
American International Group first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
American International Group's Passage Bio position peaked at $227K in Q2 2020.
85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.